These GLP-1 receptor agonists, initially developed to treat diabetes, are now being hailed as breakthrough tools for weight loss
Researchers concluded that berberine may be a good candidate for treating diabetes
Some patients may require slower titration if they experience persistent nausea or vomiting
Encourages gut health
Enzyme inhibition assays with recombinant human GSTP1, kinetic analysis, molecular docking, and molecular dynamic simulations were employed
has received research grants from Acceleron, Actelion, Bayer, Isarna, MSD, EMD Pharmaceuticals (Merck, Darmstadt), Novocure, Piqur and Roche and honoraria for lectures or advisory board participation or consulting from BMS, Celldex, Immunocellular Therapeutics, Isarna, Magforce, MSD, EMD Pharmaceuticals (Merck, Darmstadt), Northwest Biotherapeutics, Novocure, Pfizer, Roche, Teva and Tocagen